top-left-banner

Wednesday, Jul 30th

Last update05:02:28 PM GMT

TwitterLinkedinYoutubeGoogleFeed

Banner

User1

User2c

User3

You are here: BioMedTech

BioMedTech

3D cancer models collaboration unveiled

 RAFT created 3D tissue mimic showing growth and invasion into the surrounding matrix of an artificial cancer mass, tissue engineered under laboratory conditions.TAP Biosystems in Cambridge and University College London in the UK are collaborating to develop a new technology weapon designed to fight cancer.

Scientists must collaborate to meet ageing challenge

Speakers at Babraham’s ‘A Question of Ageing’ summitOnly an interdisciplinary approach by the scientific research community will solve the growing problem of disease in an ageing population, a Cambridge UK technology summit was warned.

Cambridge technology targets ‘undruggable’ cancer genes

Dr Chris TorrancePersonalised medicines pioneer Horizon Discovery has developed a new weapon in the fight against ‘undruggable’ cancer genes.

Cambridge ‘health for homeless’ breakthrough

Dawson King, CEO of Cambridge Healthcare LtdCambridge UK healthcare technology specialist How are you? has launched a new app store with The European Directory of Health Apps 2012-2013 – claiming the first-ever directory and app store of its kind.

Sareum eyes first big deal as losses deepen

Dr Tim MitchellCancer drug discovery business, Sareum, saw its losses deepen in the year to June 30 but the Cambridge UK company believes its first big deal is just around the corner.

Boost from cancer nausea study

Dr Julian GilbertA Cambridge UK pharmaceutical company has reported positive results from a new study into preventing acute nausea and vomiting in cancer patients.

Approval boost for breast cancer pioneer

Dr Andrew ShawcrossEndomagnetics, the Cambridge UK company developing technology to improve the standard of breast cancer management, has achieved certification to an international quality standard.

Vectura $10m inhaler windfall

 

Chris-BlackwellCambridge drug delivery business Vectura is set to collect a $10 million windfall from Novartis and earn subsequent royalty streams following a key approval for pioneering inhaler technology.

Page 52 of 122